Multiple Reaction Monitoring Assay Market - Forecast(2021 - 2026)

Report Code: HCR 27011 Report Format: PDF + Excel (Delivery in 48 Hrs)

Multiple Reaction Monitoring Assay Market Overview

Multiple Reaction Monitoring Assay Market size is estimated at $486 million in 2020, projected to grow at a CAGR of 5.2% during the forecast period 2021-2026. Multiple Reaction Monitoring Assay is a highly selective and sensitive technique for analyzing small molecules. 

Peptides quantifications or protein, cystic fibrosis fragments in complex biological samples are quantified using this targeted proteomics process. Instead of going through large quantities of data from non-targeted proteomics experiments, the MRM platform technology allows for selective filtering of particular proteins and developing Immunosuppressant drugs. This effective method for measuring targeted proteomics proteins quantitatively has become a standard tool in research methodologies today. Multiple reaction monitoring assays work best for peptides quantifications containing 7-17 amino acids. It is a more advanced treatment than conventional chemotherapy as it offers long-term cancer protection, has fewer side effects, and is effective against a wider range of cancer types and new-borns. 

The growing use of multiple reaction monitoring assays in research institutes, diagnostic centres, and hospitals is driving growth in the Multiple Reaction Monitoring Assay industry. For the quantification of protein, Immunosuppressant drugs and peptides quantification in a complex biological marker sample, the multiple reaction monitoring assay method is a highly selective and sensitive method. It employs mass spectroscopy to targeted proteomics and detects the appropriate proteins, as well as to look for peptides quantifications and protein fragments of interest.

Multiple Reaction Monitoring Assay Market Report Coverage

The report: Multiple Reaction Monitoring Assay Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Multiple Reaction Monitoring Assay Market.

By Type: Custom MRM Assays, Human Discovery Assay, Human Cardiovascular MRM Assay and Human Cancer MRM Assay.
By Application: Biological Marker Assessment, MRM-MS (Mass spectrometry) Quality Control - Platform Performance and Workflow Performance.
By End User: Hospitals, Diagnostic Centres and Research Institutes.
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America) and RoW (Middle East and Africa).

Key Takeaways
  • Owing to the global pandemic, medical device manufacturers are concentrating on producing critical medical devices such as ventilators and diagnostics is expected to drive demand for Multiple Reaction Monitoring Assay.
  • Geographically, North America Multiple Reaction Monitoring Assay Market held the largest revenue share of 44% in 2020 owing to the high investments in R&D and support of government investments in healthcare. In the final report, the scope of the Multiple Reaction Monitoring Assay Market for various regions will be given.
  • The Multiple Reaction Monitoring Assay Industry is being driven by technological advances in oncology care on healthy tissues.
  • Multiple reaction monitoring assays are commonly used in research institutes and diagnostic centers to measure biological markers in biological samples or to track disease like Pulmonary exacerbation and treatment progress.
Multiple Reaction Monitoring Assay Market: Market Share (%) by Region, 2020

For More Details on This Report - Request for Sample

Multiple Reaction Monitoring Assay Market Segment Analysis – By Application:

Based on Application, Multiple Reaction Monitoring Assay Market is segmented into Biological Marker Assessment, MRM-MS (Mass spectrometry) Quality Control - Platform Performance and Workflow Performance. Biological Marker Assessment accounted for the largest revenue market share in 2020 owing to increased R&D support for pharma and biotech firms, increased number of CROs and low cost of clinical trials in developing countries, high cancer incidence, and new research initiatives. Biological Markers are commonly used to diagnose and treat a variety of Pulmonary exacerbation diseases and Cystic fibrosis. The levels of Biological Markers in the body change as a result of drug administration. Multiple Biological Marker research assists physicians in making critical decisions regarding a patient's condition, disease level, treatment plan, and prognosis. Multiple Reaction Monitoring Assay Industry expansion is growing owing towards the rising global prevalence of cancer, the use of cancer Biological Markers has risen dramatically in recent years, creating opportunities to improve cancer patient care by improving diagnosis and treatment effectiveness. MRM-MS Quality Control segment is anticipated to grow with the fastest CAGR of 5.8% in the forecast period 2021-2026. The fastest growth of the segment is owing to multiplexed mass spectrometry (MS) using selected reaction monitoring for targeted proteomics, bottom-up quantification of protein Biological Markers. For instance, The PeptiQuantTM Plus Quality Control kit line is a set of simple-to-use kits for quality control in quantitative MRM-MS proteomics workflows or routine instrument quality assurance.

Multiple Reaction Monitoring Assay Market Segment Analysis – By End User:

Based on End User, Multiple Reaction Monitoring Assay Market is segmented into Hospitals, Diagnostic Centres and Research Institutes. Hospital accounted for the largest revenue market share in 2020. Improving healthcare facilities, medical diagnostic and pathological laboratories, private-public ventures, and the health insurance sector are likely to drive the development. Furthermore, with the increase of societal health consciousness and the increasing burden of cardiovascular and Pulmonary exacerbation Pulmonary exacerbation diseases and Cystic fibrosis the demand for Multiple Reaction Monitoring Assay Industry is increasing. Diagnostic Centres segment is anticipated to grow with the fastest CAGR of 5.5% during the forecast period 2021-2026. The demand for medical services is expected to expand as knowledge and affordability rise, as is already the case in many developed countries, where healthcare services contribute significantly to GDP growth, thereby, expanding the Multiple Reaction Monitoring Assay Market.

Multiple Reaction Monitoring Assay Market Segment Analysis - By Geography:

Based on Geography, North America Multiple Reaction Monitoring Assay Market accounted for the 44% revenue share in 2020 owing towards the presence of several key players in the region. In the United States, cardiovascular Pulmonary exacerbation diseases and Cystic fibrosis appears to be the leading cause of morbidity and mortality. Companies in this market are concentrating their efforts on discovering cardiac Biological Markers in order to gain a better understanding of the pathophysiology of these Pulmonary exacerbation Pulmonary exacerbation diseases and Cystic fibrosis. Most major players are undertaking a range of strategic strategies, such as mergers and acquisitions, new product growth, and public awareness campaigns, in order to retain or boost their Biological Marker market position. For instance, Roche Diagnostics Biological Marker assay for bladder cancer was approved by the Food and Drug Administration (FDA) in May 2017. By using both tumor cell staining and immune cell staining and scoring inside the tumor, Pulmonary exacerbation Pulmonary exacerbation diseases and Cystic fibrosis, the assay test will determine a patient's PD-L1 status aiding towards the Multiple Reaction Monitoring Assay Industry. Asia-Pacific is predicted to be the fastest growing region during the forecast period 2021- 2026. The presence of leading Biological Marker players in the region, strategic initiatives for product co-development, and increased R&D investment in developing countries are some of the factors driving growth. The cost of clinical trials in developing economies is lower than in developed economies, which is expected to have a positive impact on the expansion.

Multiple Reaction Monitoring Assay Market Drivers 

The Increasing Diagnostic Applications:

Multiple Reaction Monitoring Assays play an important role in personalized medicine, with applications such as diagnosis, prognosis, and therapy collection. Owing to many shortcomings of conventional diagnosis and treatment methods, personalized medicine has gained popularity over time. From cancer to immunological disorders, several fields of medicine are shifting toward personalized care for specific patients based on their genetic signatures and clinical characteristics. Companion diagnostics and Biological Markers have become increasingly significant in medical practice, resulting in better diagnosis, care, and monitoring in a variety of disease areas like Pulmonary exacerbation diseases and Cystic fibrosis. It can be used to recognise patients who are likely to react well to certain medications or treatments. These tests are often used in combination with a particular medication has benefited the global Multiple Reaction Monitoring Assay market's growth trajectory. Furthermore, the rising disease burden, together with the broader population in these geographic segments, is a key factor in higher growth expectations in these areas. In addition, the increasing number of hospitals globally presents significant opportunities for Multiple Reaction Monitoring Assay manufacturers.

Multiple Reaction Monitoring Assay Market Challenges 

High Initial Capital Expenditures And A Low Cost-Benefit Ratio:

Multiple Reaction Monitoring Assay discovery, growth, and validation necessitate major financial investments. This stifles the market and related markets' growth, such as diagnostics and personalized medicines. The current ability to validate candidate Biological Markers greatly outpaces its discovery. The customized medicines industry faces a significant challenge in this regard. Diagnostics manufacturers also face major financial challenges as a result of the high drug attrition rate in clinical trials. Strict regulatory requirements and a shortage of standardization resources in some developed and developing countries are two major factors that are expected to hinder Multiple Reaction Monitoring Assay market growth. Clinical trials and meeting strict regulatory criteria necessitate significant investments, which not only limit small companies' ability to produce Biological Markers but also stifle innovation. As a result, business growth is hampered by both high capital costs and a poor cost-benefit ratio.

Multiple Reaction Monitoring Assay Market Landscape:

The Multiple Reaction Monitoring Assay Market's main strategies include product releases, mergers and acquisitions, joint ventures, and regional expansion. Multiple Reaction Monitoring Assay Market top 10 companies are MRM Proteomics, Sigma Aldrich, Luminex Corporation, Becton, Dickinson and Company, Alphalyse, Proteomics, Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V. and Thermo Fisher Scientific.

Acquisitions/Product Launches:

In October 2020, Becton, Dickinson and Company acquired San Diego biomedical business CareFusion for $12.2 billion. By addressing unmet needs in hospitals, hospital pharmacies, and alternative sites of treatment, the acquisition would enhance patient care efficiency and lower health-care costs by increasing efficiencies and reducing Immunosuppressant drugs administration errors.

Related Reports

 Cancer Biological Markers Market - Forecast(2021 - 2026)

Report Code: HCR 0194

 Biological Markers Market - Forecast(2021 - 2026)

Report Code: HCR 0059

For more Lifesciences and Healthcare Market reports, please click here

1. Multiple Reaction Monitoring Assay Market - Overview
    1.1 Definitions and Scope
2. Multiple Reaction Monitoring Assay Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends by Application
    2.3 Key trends by End User
    2.4 Key trends by Geography
3. Multiple Reaction Monitoring Assay Market - Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis– Key Companies
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Multiple Reaction Monitoring Assay Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Multiple Reaction Monitoring Assay Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Multiple Reaction Monitoring Assay Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Multiple Reaction Monitoring Assay Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Multiple Reaction Monitoring Assay Market – By Type (Market Size –$Million/$Billion)
    8.1 Custom MRM Assays
    8.2 Human Discovery Assay
    8.3 Human Cardiovascular MRM Assay
    8.4 Human Cancer MRM Assay
9. Multiple Reaction Monitoring Assay Market – By Application (Market Size –$Million/$Billion)
    9.1 Biomarker Assessment
    9.2 MRM-MS Quality Control
        9.2.1 Platform Performance
        9.2.2 Workflow Performance
10. Multiple Reaction Monitoring Assay Market – By End User (Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Diagnostic Centers
    10.3 Research Institutes
11. Multiple Reaction Monitoring Assay Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Multiple Reaction Monitoring Assay Market - Entropy
13. Multiple Reaction Monitoring Assay Market – Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Multiple Reaction Monitoring Assay Market – Key Company List by Country Premium Premium
15. Multiple Reaction Monitoring Assay Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global MULTIPLE REACTION MONITORING ASSAY MARKET, BY ASSAY TYPE Market 2019-2024 ($M)
1.1 CUSTOM ASSAY Market 2019-2024 ($M) - Global Industry Research
1.2 HUMAN DISCOVERY ASSAY Market 2019-2024 ($M) - Global Industry Research
1.3 HUMAN CANCER ASSAY Market 2019-2024 ($M) - Global Industry Research
1.4 HUMAN CARDIOVASCULAR ASSAY Market 2019-2024 ($M) - Global Industry Research
2.Global MULTIPLE REACTION MONITORING ASSAY MARKET, BY END USE Market 2019-2024 ($M)
2.1 HOSPITALS Market 2019-2024 ($M) - Global Industry Research
2.2 DIAGNOSTIC CENTRES Market 2019-2024 ($M) - Global Industry Research
2.3 RESEARCH INSTITUTES Market 2019-2024 ($M) - Global Industry Research
3.Global MULTIPLE REACTION MONITORING ASSAY MARKET, BY ASSAY TYPE Market 2019-2024 (Volume/Units)
3.1 CUSTOM ASSAY Market 2019-2024 (Volume/Units) - Global Industry Research
3.2 HUMAN DISCOVERY ASSAY Market 2019-2024 (Volume/Units) - Global Industry Research
3.3 HUMAN CANCER ASSAY Market 2019-2024 (Volume/Units) - Global Industry Research
3.4 HUMAN CARDIOVASCULAR ASSAY Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global MULTIPLE REACTION MONITORING ASSAY MARKET, BY END USE Market 2019-2024 (Volume/Units)
4.1 HOSPITALS Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 DIAGNOSTIC CENTRES Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 RESEARCH INSTITUTES Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America MULTIPLE REACTION MONITORING ASSAY MARKET, BY ASSAY TYPE Market 2019-2024 ($M)
5.1 CUSTOM ASSAY Market 2019-2024 ($M) - Regional Industry Research
5.2 HUMAN DISCOVERY ASSAY Market 2019-2024 ($M) - Regional Industry Research
5.3 HUMAN CANCER ASSAY Market 2019-2024 ($M) - Regional Industry Research
5.4 HUMAN CARDIOVASCULAR ASSAY Market 2019-2024 ($M) - Regional Industry Research
6.North America MULTIPLE REACTION MONITORING ASSAY MARKET, BY END USE Market 2019-2024 ($M)
6.1 HOSPITALS Market 2019-2024 ($M) - Regional Industry Research
6.2 DIAGNOSTIC CENTRES Market 2019-2024 ($M) - Regional Industry Research
6.3 RESEARCH INSTITUTES Market 2019-2024 ($M) - Regional Industry Research
7.South America MULTIPLE REACTION MONITORING ASSAY MARKET, BY ASSAY TYPE Market 2019-2024 ($M)
7.1 CUSTOM ASSAY Market 2019-2024 ($M) - Regional Industry Research
7.2 HUMAN DISCOVERY ASSAY Market 2019-2024 ($M) - Regional Industry Research
7.3 HUMAN CANCER ASSAY Market 2019-2024 ($M) - Regional Industry Research
7.4 HUMAN CARDIOVASCULAR ASSAY Market 2019-2024 ($M) - Regional Industry Research
8.South America MULTIPLE REACTION MONITORING ASSAY MARKET, BY END USE Market 2019-2024 ($M)
8.1 HOSPITALS Market 2019-2024 ($M) - Regional Industry Research
8.2 DIAGNOSTIC CENTRES Market 2019-2024 ($M) - Regional Industry Research
8.3 RESEARCH INSTITUTES Market 2019-2024 ($M) - Regional Industry Research
9.Europe MULTIPLE REACTION MONITORING ASSAY MARKET, BY ASSAY TYPE Market 2019-2024 ($M)
9.1 CUSTOM ASSAY Market 2019-2024 ($M) - Regional Industry Research
9.2 HUMAN DISCOVERY ASSAY Market 2019-2024 ($M) - Regional Industry Research
9.3 HUMAN CANCER ASSAY Market 2019-2024 ($M) - Regional Industry Research
9.4 HUMAN CARDIOVASCULAR ASSAY Market 2019-2024 ($M) - Regional Industry Research
10.Europe MULTIPLE REACTION MONITORING ASSAY MARKET, BY END USE Market 2019-2024 ($M)
10.1 HOSPITALS Market 2019-2024 ($M) - Regional Industry Research
10.2 DIAGNOSTIC CENTRES Market 2019-2024 ($M) - Regional Industry Research
10.3 RESEARCH INSTITUTES Market 2019-2024 ($M) - Regional Industry Research
11.APAC MULTIPLE REACTION MONITORING ASSAY MARKET, BY ASSAY TYPE Market 2019-2024 ($M)
11.1 CUSTOM ASSAY Market 2019-2024 ($M) - Regional Industry Research
11.2 HUMAN DISCOVERY ASSAY Market 2019-2024 ($M) - Regional Industry Research
11.3 HUMAN CANCER ASSAY Market 2019-2024 ($M) - Regional Industry Research
11.4 HUMAN CARDIOVASCULAR ASSAY Market 2019-2024 ($M) - Regional Industry Research
12.APAC MULTIPLE REACTION MONITORING ASSAY MARKET, BY END USE Market 2019-2024 ($M)
12.1 HOSPITALS Market 2019-2024 ($M) - Regional Industry Research
12.2 DIAGNOSTIC CENTRES Market 2019-2024 ($M) - Regional Industry Research
12.3 RESEARCH INSTITUTES Market 2019-2024 ($M) - Regional Industry Research
13.MENA MULTIPLE REACTION MONITORING ASSAY MARKET, BY ASSAY TYPE Market 2019-2024 ($M)
13.1 CUSTOM ASSAY Market 2019-2024 ($M) - Regional Industry Research
13.2 HUMAN DISCOVERY ASSAY Market 2019-2024 ($M) - Regional Industry Research
13.3 HUMAN CANCER ASSAY Market 2019-2024 ($M) - Regional Industry Research
13.4 HUMAN CARDIOVASCULAR ASSAY Market 2019-2024 ($M) - Regional Industry Research
14.MENA MULTIPLE REACTION MONITORING ASSAY MARKET, BY END USE Market 2019-2024 ($M)
14.1 HOSPITALS Market 2019-2024 ($M) - Regional Industry Research
14.2 DIAGNOSTIC CENTRES Market 2019-2024 ($M) - Regional Industry Research
14.3 RESEARCH INSTITUTES Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
2.Canada Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
3.Mexico Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
4.Brazil Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
5.Argentina Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
6.Peru Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
7.Colombia Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
8.Chile Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
9.Rest of South America Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
10.UK Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
11.Germany Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
12.France Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
13.Italy Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
14.Spain Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
15.Rest of Europe Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
16.China Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
17.India Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
18.Japan Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
19.South Korea Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
20.South Africa Multiple Reaction Monitoring Assay Market Revenue, 2019-2024 ($M)
21.North America Multiple Reaction Monitoring Assay By Application
22.South America Multiple Reaction Monitoring Assay By Application
23.Europe Multiple Reaction Monitoring Assay By Application
24.APAC Multiple Reaction Monitoring Assay By Application
25.MENA Multiple Reaction Monitoring Assay By Application
26.SIGMA ALDRICH, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.THERMO FISHER SCIENTIFIC, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.ALPHALYSE, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.PROTEOMICS, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.LUMINEX CORPORATION, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.BECTON, DICKINSON AND COMPANY, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.ILLUMINA, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.BIO-RAD LABORATORIES, INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.QIAGEN N.V., Sales /Revenue, 2015-2018 ($Mn/$Bn)